A cloud-based platform for improving cancer treatment with radiation therapy
Official title: Cloud/Web-Based Platform for Quantitative SPECT Reconstruction of Therapeutic Radionuclides
Funded at Radiopharmaceutical Imaging and Dosimetry, LLC · NIH-11069459 · Data updated 2026-11-12
This study is creating an online tool that helps doctors give the right amount of radiation for cancer treatment by using advanced imaging, so patients can receive more personalized care based on their specific tumors.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Radiopharmaceutical Imaging and Dosimetry, LLC NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project start | February 1, 2025 |
| Project end | January 31, 2027 |
| Funding year | 2025 |
| Award (this year) | $1,003,173 |
| NIH project number | 1R44CA291419-01A1 |
| Project ID | NIH-11069459 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are cancer patients undergoing or considering radiopharmaceutical therapy.
✕Less likely to help
Patients with non-cancerous conditions or those not eligible for radiopharmaceutical therapy may not receive any benefit from this research.
What this research studies
This research focuses on developing a cloud/web-based platform that enhances the quantitative imaging and dosimetry of therapeutic radionuclides used in cancer treatment. By utilizing advanced imaging techniques, the platform aims to provide precise dosimetry, which is crucial for the effective application of radiopharmaceutical therapy (RPT). Patients will benefit from a more personalized approach to their cancer treatment, as the platform will help tailor radiation doses to individual tumor characteristics. The methodology involves integrating data from various imaging sources to improve the accuracy of radiation delivery to cancer cells.
Why it matters
Potential benefit: If successful, this research could lead to more effective and personalized cancer treatments through improved radiation therapy.
How similar studies have gone: Other research has shown success in using advanced imaging techniques for cancer treatment, indicating that this approach has potential for significant advancements.
Where this research is happening
-
Radiopharmaceutical Imaging and Dosimetry, LLC
Baltimore, United States Active
Researchers
- Principal investigator: Ghaly, Michael — Radiopharmaceutical Imaging and Dosimetry, LLC
- Study coordinator: Ghaly, Michael
Related research
Other NIH-funded projects on the same topics.
-
A tool for measuring radiation doses from alpha-particle cancer treatments
This study is creating a new online tool to help doctors better measure the radiation doses used in cancer treatments with alpha particles, making sure they target cancer cells effectively while protecting healthy tissues, so patients can receive safer and more effective care.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.